Calquence (acalabrutinib) is a prescription medication used to treat certain types of blood cancers such as mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and small lymphocytic lymphoma (SLL). It works by inhibiting Bruton tyrosine kinase (BTK), a protein that helps cancer cells grow and survive.